Virginia-based, Zephyr AI is a health-tech company that develops AI for precision medicine, recently raised $111 million led by Revolution Growth in a Series A round.
The round was actively backed by Jeff Skoll, Eli Lilly & Company, EPIQ Capital Group, and others.
Zephyr AI $111M Series Barrie
CEO and Co-founder Zephyr AI, Grant Verstandig said in an interview that the funds raised will be used for further development, training, R&D, and expansion across the US market.
Co-founder and CTO, Jeff Sherman said that Zephyr AI is working on various Machine Learning programs in cardiometabolic and oncology treatment.
Moreover, through healthcare partnerships, Zephyr AI curated a dataset of algorithms for AI that can help in patient care and life support, and research disease in detail.
Also Read: Sound Raised $20M Series A